These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12700707

  • 1. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 2. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
    Zwanzger P, Baghai TC, Schuele C, Ströhle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2001 Nov; 25(5):699-703. PubMed ID: 11682253
    [Abstract] [Full Text] [Related]

  • 3. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Nov; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

  • 4. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
    Eser D, Leicht G, Baghai T, Pogarell O, Schüle C, Karch S, Nothdurfter C, Rupprecht R, Mulert C.
    J Psychiatr Res; 2009 Jan; 43(4):393-400. PubMed ID: 18534623
    [Abstract] [Full Text] [Related]

  • 5. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A, Holsboer F, Rupprecht R.
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [Abstract] [Full Text] [Related]

  • 6. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    World J Biol Psychiatry; 2012 Oct; 13(7):526-34. PubMed ID: 22111662
    [Abstract] [Full Text] [Related]

  • 7. Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans.
    Leicht G, Mulert C, Eser D, Sämann PG, Ertl M, Laenger A, Karch S, Pogarell O, Meindl T, Czisch M, Rupprecht R.
    Biol Psychiatry; 2013 Feb 15; 73(4):337-44. PubMed ID: 23059050
    [Abstract] [Full Text] [Related]

  • 8. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P, Eser D, Völkel N, Baghai TC, Möller HJ, Rupprecht R, Padberg F.
    Int J Neuropsychopharmacol; 2007 Apr 15; 10(2):285-9. PubMed ID: 16817979
    [Abstract] [Full Text] [Related]

  • 9. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, Rupprecht R, Romeo E.
    Neuropsychopharmacology; 2005 Jan 15; 30(1):192-5. PubMed ID: 15467707
    [Abstract] [Full Text] [Related]

  • 10. The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam.
    Rohrer T, von Richthofen V, Schulz C, Beyer J, Lehnert H.
    Horm Metab Res; 1994 Apr 15; 26(4):200-6. PubMed ID: 8082875
    [Abstract] [Full Text] [Related]

  • 11. Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects.
    Zwanzger P, Zavorotnyy M, Gencheva E, Diemer J, Kugel H, Heindel W, Ruland T, Ohrmann P, Arolt V, Domschke K, Pfleiderer B.
    Neuropsychopharmacology; 2013 Aug 15; 38(9):1648-54. PubMed ID: 23463151
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam.
    Fries E, Hellhammer DH, Hellhammer J.
    Psychoneuroendocrinology; 2006 Nov 15; 31(10):1278-88. PubMed ID: 17097811
    [Abstract] [Full Text] [Related]

  • 13. Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol.
    Abelson JL, Curtis GC, Cameron OG.
    J Psychiatr Res; 1996 Nov 15; 30(2):79-93. PubMed ID: 8816303
    [Abstract] [Full Text] [Related]

  • 14. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder.
    Masdrakis VG, Markianos M, Oulis P.
    Psychiatry Res; 2015 Sep 30; 229(1-2):75-81. PubMed ID: 26243374
    [Abstract] [Full Text] [Related]

  • 15. Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?
    Demiralay C, Agorastos A, Yassouridis A, Jahn H, Wiedemann K, Kellner M.
    Psychoneuroendocrinology; 2017 Feb 30; 76():14-18. PubMed ID: 27871026
    [Abstract] [Full Text] [Related]

  • 16. CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers.
    van Duinen MA, Schruers KR, Maes M, Griez EJ.
    J Psychopharmacol; 2005 May 30; 19(3):243-7. PubMed ID: 15888509
    [Abstract] [Full Text] [Related]

  • 17. Effects of propranolol on symptom and endocrine responses to pentagastrin.
    Khan S, Liberzon I, Abelson JL.
    Psychoneuroendocrinology; 2004 Oct 30; 29(9):1163-71. PubMed ID: 15219640
    [Abstract] [Full Text] [Related]

  • 18. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P, Eser D, Padberg F, Baghai TC, Schule C, Rötzer F, Ella R, Möller HJ, Rupprecht R.
    Depress Anxiety; 2003 Oct 30; 18(3):140-3. PubMed ID: 14625878
    [Abstract] [Full Text] [Related]

  • 19. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
    Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Demazières A, Luthringer R.
    J Psychopharmacol; 2011 Jan 30; 25(1):52-9. PubMed ID: 20498136
    [Abstract] [Full Text] [Related]

  • 20. Cholecystokinin tetrapeptide effects on HPA axis function and elevated plus maze behaviour in maternally separated and handled rats.
    Greisen MH, Bolwig TG, Wörtwein G.
    Behav Brain Res; 2005 Jun 20; 161(2):204-12. PubMed ID: 15922046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.